NEW YORK, May 31 (GenomeWeb News) - Chondrogene's first-quarter revenue declined around 1 percent as R&D spending surged 85 percent and net losses 26.5 percent year over year, the company reported today.

 

Total receipts for the three months ended March 31 declined to CA$868,222 ($788,312) from CA$878,251 year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.